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1. Introduction
Inflammatory or degenerative processes in glenohumeral joint lead to pain and restriction
of  movements  of  the  shoulder.  Prosthetic  replacement  of  the  glenohumeral  joint  has
gained in  popularity  because of  its  efficacy in  relieving pain.  The pioneering successful
prostheses for total shoulder arthroplasty (TSA) have been based on an unconstrained de‐
sign, i.e. a metal spherical head component fixed to a metal intramedullary stem articulat‐
ing  with  a  high-density  polyethylene  socket.  These  components  are  stabilized  in  the
adjacent bone using polymethylmethacrylate (PMMA) bone cement [1]. The most impor‐
tant  cause  for  failure  of  the  cemented  prostheses  is  related  to  the  glenoid  component,
with a 0.01-6% rate of loosening [2, 3, 4].
The long term survivorship data of the prosthesis developed by C. Neer for the cemented
total shoulder arthroplasty (TSA) show 87% fifteen year survivorship rate for Neer I & II ce‐
mented shoulder prostheses [5]. This implant has become the gold standard, against which
all the successive prosthetic designs are compared.
Further developments of TSA implants have been aimed at enhancing longevity by address‐
ing the following most critical issues: (1) Improving the incorporation of the glenoid compo‐
nent using a more "biological" type of fixation in order to reduce the rate of mechanical
loosening; (2) Designing a better glenoid component to achieve the lowest possible rate of
wear. But still the main cause of TSA failure has remained the aseptic loosening of the gle‐
noid component [6].
© 2013 Rosenberg et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Aseptic loosening
Aseptic loosening of endoprostheses occurs as a result of immune rejection response to an
implanted foreign material. This response is enhanced when particles of polyethylene (from
the glenoid insert), metal (from the glenoid metal backplate and/or from humeral compo‐
nent) or from fixating PMMA are released due to a mechanically abnormal gliding of the
prosthesis. These particles, below 10μ in size, usually in 0.5-1.0μ range [7], induce local and
systemic recruitment of macrophages and osteoclasts [8], with subsequential generation of
reactive pseudomembrane and local lysis of the prosthesis-bone interface [9] (Figure 1). The
lysis of the fixation interface of the prosthesis causes its eventual loosening. Since in the TSA
prosthesis the glenoid component is exposed to the higher stresses and usually constructed,
at least partly, from polyethylene, it’s loaded surface is prone to wear and its surrounding is
exposed to the wear particles’ seeding. For this reason the immune rejection response is con‐
centrated mainly around the glenoid component.
Figure 1. Micrograph (scale 200μ, HE staining) of pseodocapsule retrieved from the surface of a failed prosthesis.
Characteristic foreign body reaction [10] is evident around areas of debris (*).
3. Mechanical considerations
The main cause of the wear of the glenoid component is its high loading by the eccentric
forces. The excessive eccentric forces are generated when the transverse axis of the implant‐
ed glenoid is situated in a position which is incompatible with normal anatomical version of
glenoid, e. g. between 20 of anteversion and 130 of retroversion [11]. This might happen
when the prosthesis is implanted in an arthritic joint with advanced erosion of the posterior
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glenoid. Therefore care should be taken to reshape the glenoid towards an anteverted sur‐
face, in the physiological range, prior to implantation of the glenoid component [12].
In the longitudinal axis the excessive eccentric forces are generated when the superior stabi‐
lization of the humeral head is insufficient, therefore in patients with massive tears of the
rotator cuff muscles an implantation of the glenoid component is contraindicated.
The full conformity between the TSA prosthesis components may also lead to an enhanced
stress on the globoid rim due to the loss of the humeral head translation, which is possible
in the normal shoulder joint, and as a consequence there is a higher risk for prosthetic loos‐
ening. [13,14]. The exact degree of optimal mismatch of the glenoid and the humeral head
radii is not known. Furthermore the suboptimal mismatch of the glenoid and humeral com‐
ponent curvature can lead to a considerable rate of polyethylene wear due to an uneven
force distribution between the components and a point loading and a point wear of the
polyethylene [14].
4. Material considerations
There are several unique issues in TSA that should be addressed in the prosthesis design.
First is a limited space and a limited bone stock for the glenoid component implantation.
Two main difficulties arise due to this limitation:
1. The fixation area of the glenoid component is limited, either for cemented or cementless
fixation. In order to increase fixation interface the glenoid components bear keels (cen‐
tral or in offset position), pegs (straight or tapered) and/or curved backsurface of the in‐
sert. It is not clear what type of fixation design is optimal for the cemented fixation [11].
There is some clinical evidence that a central tapered peg on a metal back-plate, covered
by hydroxyapatite for enhanced ossiointegration, and initially fixed by two screws,
might reduce loosening rate of glenoid component in cementless press fit fixation [15]
(Figure 2).
2. The polyethylene gliding surface is essential in most designs of the glenoid component.
The polyethylene surface should be at least 3 mm thick, preferably 4-6 mm thick, in or‐
der to diminish its wear following interaction with metal head of the humeral compo‐
nent [16]. This requirement prevents the versatile use of the cementless designs of a
glenoid component, because they require the use of a metal back-plate under the poly‐
ethylene insert, with essential limitation of the later thickness in order to prevent the
joint overstuffing. For this reason there is a high preference for use of all polyethylene
made glenoid components for cemented implantation. This type of design allows the
use of more thick polyethylene component, with lower wear rate. But the cemented fix‐
ation of this type of glenoid component might produce thermal mediated, adjacent to
the implant, bone necrosis while PMMA polymerization and therefore eventually an
enhanced loosening. Currently there is no clear information which of the fixation meth‐
ods of the glenoid component is clinically advantageous.
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Figure 2. An example of glenoid component for cementless implantation: a polyethylene insert mounted on a metal
back-plate with tapered peg covered by hydroxyapatite. The initial press fit fixation is enhanced by two screws. This
design showed improved survivorship rates.
5. Clinical signs of the glenoid component loosening
The clinical signs of the TSA prosthesis failure include an increased level of pain during fol‐
low-up, that appeared to be related to the implant, with restriction of external rotation to
under 20o and abduction to under 60o and/or newly developed radiolucency at the glenoid
component interface with the underlying bone, more than 2mm in width [17]. The recogni‐
tion of coexistence of both physical and radiographic signs is essential, since the isolated
finding of periprosthetic radiolucency, without pain or significant restriction of movements
of the shoulder, might not be of a high clinical importance (Figure 3). This consideration
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should be undertaken carefully in order to avoid unnecessary revision surgery. In all the
cases of suspected TSA prosthesis loosening a standard workup for possible periprosthetic
infection should be done in order to avoid a devastating misdiagnosis [18] (the discussion of
this topic is out of the scope of the present chapter).
Figure 3. A shoulder radiograph (anterior-posterior view) of 60 years old male patient, three years after cemented
TSA. Lucency is evident in the direct proximity to the glenoid component, but the patient is pain free and has good
range of movements of the operated shoulder, without any laboratory evidence of infection and is satisfied from the
function of the operated shoulder.
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6. Survivorship data of TSA prostheses with special emphasis on glenoid
loosening
In order to get a meaningful evaluation of the implanted prostheses longevity a powerful
statistical tool of survivorship analysis is used [19]. Because the relative complicity in this
method implementation, especially in defining the criteria for the “failure” of the implanted
prostheses, only few reports on survivorship data of TSA exist, mainly with the parameter
of a revision surgery as the indication of the failed prosthesis.
From the few reported survivorship data a short-term glenoid failure, requiring implant re‐
moval, reaches the rate of around 6% for cemented designs and 3% for cementless designs.
Overall the glenoid component failure is the cause of between 20% - 60% of all failed TSAs,
cemented or cementless (Table 1). Survivorship of TSA is the highest in patients with rheu‐
matoid arthritis and the lowest in patients implanted following trauma and fracture. The
reason is probably a lower demand for shoulder activity in the former group and expecta‐
tions for nearly normal function in the latter group of patients [20, 21, 22, 23].
Reference Type ofprosthesis No. of Patients Survivorship
End point
criteria
Glenoid
failure rate
Overall
failure rate
Tarchia et al
[21]
Neer I & II
cemented
113
[31=OA,
36=RA
12=2ary OA]
10years= 93%
15years= 87%
Revision – severe
pain, abd<90o,
ext rot<20o
7/113 14/113
Brenner et al
[23]
Neer II &
Gristina
cemented
51
[37=OA
14=RA]
11years= 75%
Severe pain,
radiographic
evidence of
component
loosening
3/51 6/51
Cofield [22] Cofieldcementless
180
[110=OA
28=RA
30=2ary OA
12=revisions]
Not calculated Revision 5/180 12/180
Pfahler et al
[20]
Aequalis
cemented
705
[418=OA 107=RA
180=2ary OA]
Not calculated Revision 9/705 43/705
OA = osteoarthritis, RA = rheumatoid arthritis
Table 1. Long term survivorship data on cemented and the outcome of a large series of a cementless total shoulder
replacement prostheses.
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7. Treatment of loose glenoid
Surgical revision of failed glenoid should address several crucial factors. One of the main
factors for consideration is the preservation of an adequate bone stock following the compo‐
nent removal. This is essential if replantation is considered, otherwise the component resec‐
tion will be the definite procedure. Interestingly several authors reported that a resection of
the failed glenoid component without subsequential replantation of a new component might
cause a considerably favorable clinical outcome [24].
The second crucial factor is the preservation of adequate version of the remained glenoid in
order to avoid future eccentric loads on the replanted glenoid component.
These two factors can be achieved by bone grafting, autologous or by allograft, with addi‐
tional controlled reaming of the remained glenoid surface. The surgeon’s arsenal of glenoid
components for replantation includes parts for either cemented or cementless fixation, and
biological soft tissue allografts for biological resurfacing. Several reports support the use of
soft tissue allograft material, e.g. Achilles tendon, meniscus etc., for glenoid resurfacing in
revision surgery [25]. Finally the replantation of the glenoid component might be immedi‐
ate, during the revision surgery, or late, following initial bone grafting of cavitations and/ or
bone deficiencies in the treated glenoid. Since this type of surgery has no standard guide‐
lines because of the different patterns of the bone loss of the treated glenoids, a precise sur‐
gical protocol does not exist for this purpose and a lot of the decision making depends on
the surgeon’s experience and methodical preferences.
In order to avoid an extensive tissue damage during the glenoid revision surgery an arthro‐
scopic approach has been suggested and reported in a small number of published reports.
This method was popularized by O’Driscoll SW et al [26]. The authors used an arthroscopic
approach through the standard anterior and posterior portals, with addition of another ex‐
tended portal for the glenoid component remnants’ retrieval. This method is suitable only
for all-polyethylene components, because they should be cut in situ to at least 3 parts (by
diagonal cuts using an inserted through the portal osteotom) in order to retrieve pieces in
sizes which are compatible with the retrieval portal diameter. This method allows also a
subsequential bone grafting of the exposed glenoid undersurface by using metal impactors
which are inserted through the created portals [27]. This is a technically demanding techni‐
que, especially due to the optical interference, e.g. “mirror effect”, that is caused by the met‐
al humeral component head and due to the difficulty to control bleeding from the exposed
glenoid surface. But because of the appealing tissue preservation this method might gain
more widespread use in the future.
8. Prospective on the future improvement of the glenoid component
design
Two main issues should be considered when seeking the improvement of the TSA survivor‐
ship. First of all the currently used TSA methods have already reached a high, above 90%,
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middle and long term survivorship rate, leaving a small, but important margin for improve‐
ment [21]. Secondary it is clear that this margin for improvement is related to the glenoid
component design, since most of the failed TSAs are due to glenoid component failure.
There is an example supporting this claim, when following a change of the design of the gle‐
noid component a 10% increase in a short term survivorship of cementless TSA prosthesis
has been achieved [15].
Clearly the main changes in the glenoid component design should address the rate of wear
of this component and the efficiency of the component fixation. Therefore it is logical that
the prospective for improvement of these issues will be related to finding the articulating
surfaces generating less wear particles, even when subjected to excessive eccentric loading.
Probably improving the biological osseous integration into the glenoid component will
solve the complications of the current fixation either by the PMME or by the mechanical
press fit fixation techniques. Some indications of the efficiency of biological fixation of the
glenoid component have been already revealed in the devices coated by osteoconductive
material, such as hydroxyapatite.
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